UNH "Remarkable Story:" Road to Recovery Ahead After Reaffirming FY25 EPS Guidance

Core Viewpoint - United Health has experienced significant volatility, with a recent upward movement, but remains down approximately 44% from its yearly highs of over $600, currently valued around $300 billion [2][3]. Financial Performance - The company declared a large premium mispricing for 2025, which has been a negative catalyst for its stock performance [2][3]. - Institutional investors are encouraged by the reaffirmation of guidance for the full fiscal year, estimated at around $16 per quarter, indicating potential for share accumulation [4]. Market Sentiment - The stock has seen a recovery from lows of approximately $234 in mid-July, reflecting a significant $100 increase [6]. - There is a bullish technical pattern emerging, suggesting potential for further upward movement towards previous levels around $373 [8]. Earnings Outlook - Upcoming earnings reports are critical, and the reaffirmation of guidance may lead to higher earnings projections post-reporting [8][10]. - The company is under scrutiny from the Department of Justice, but the reaffirmation of guidance suggests confidence in navigating this investigation [13]. Government Influence - United Health's performance is closely tied to government spending, particularly in relation to Medicare Advantage plans, which has been a focal point of recent discussions [10][11].